U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663630) titled 'A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss' on June 17.
Brief Summary: Study to investigate the effect of ponsegromab on skeletal muscle mass and physical function in adult participants with non-small cell lung cancer associated cachexia.
Study Start Date: July 22
Study Type: INTERVENTIONAL
Condition:
Non-small Cell Lung Cancer (NSCLC)
Cachexia
Intervention:
DRUG: ponsegromab
Double-Blind ponsegromab Treatment
DRUG: placebo
Double-Blind placebo Treatment
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Pfizer
Published by HT Digital Content Se...